Ryo Ariyasu

PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes

Joji Nagasaki, Takashi Inozume, Nicolas Sax et al. · Cell Reports · 2022 · 114 citations · Full text

Life Sciences, Immunology, Oncology +14

High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer

Ryo Ariyasu, Shingo Nishikawa, Ken Uchibori et al. · Lung Cancer · 2018 · 53 citations

Medicine, Oncology, Pharmacology +17

Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy

Ryo Ariyasu, Atsushi Horiike, Takahiro Yoshizawa et al. · Anticancer Research · 2017 · 50 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017

Natsuki Takano, Ryo Ariyasu, Junji Koyama et al. · Lung Cancer · 2019 · 43 citations

Medicine, Oncology, Surgery +11

Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment

Takehiro Tozuka, Satoru Kitazono, Hiroaki Sakamoto et al. · Lung Cancer · 2020 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +11